Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.

Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.

INTRODUCTION: Patients on intravenous heparin require regular activated partial thromboplastin time monitoring. Laboratory-based activated partial thromboplastin time assays necessitate a delay between blood sampling and dose adjustment. Point-of-care testing could permit immediate dose adjustments...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Douglas, A, Jefferis, J, Sharma, R, Parker, R, Handa, A, Chantler, J
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registros relacionados

Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy
por: Kevin McLaughlin PharmD, BCPS, et al.
Publicado em: (2019-09-01)

The use of activated partial thromboplastin time versus antifactor Xa assay in monitoring continuous unfractionated heparin infusion therapy in obstetric intensive care unit
por: Hany V. Zaki, et al.
Publicado em: (2019-02-01)

PARTIAL THROMBOPLASTIN TIME CHANGES IN ASTHMA
por: A MIRALAEI, et al.
Publicado em: (2003-03-01)

A Recurrent Neural Network Model for Predicting Activated Partial Thromboplastin Time After Treatment With Heparin: Retrospective Study
por: Sebastian Daniel Boie, et al.
Publicado em: (2022-10-01)

An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation
por: Yuan Teng, et al.
Publicado em: (2022-06-01)

Effect of plasma storage on prothrombin time and activated partial thromboplastin time at a Nigerian public laboratory
por: Mohammed A Ndakotsu, et al.
Publicado em: (2013-01-01)

Evaluation of the Activated Partial Thromboplastin Time (aPTT) Sensitivity to Unfractionated Heparin Using Three Commercial Reagents: Implication for Therapeutic Range
por: Nisarat Opartkiattikul, et al.
Publicado em: (2005-12-01)

Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis
por: Edward Kurnia Setiawan Limijadi, et al.
Publicado em: (2016-05-01)

Performance Evaluation of Four Activated Partial Thromboplastin Time Reagents
por: Peppi Z. Yuzaqi, et al.
Publicado em: (2018-08-01)

THE EVALUATION OF HEALTHY CHILDREN WITH INCIDENTAL PROLONGATION OF PROTHROMBIN OR ACTIVATED PARTIAL THROMBOPLASTIN TESTS
por: Gökcen MERAL, et al.
Publicado em: (2021-11-01)

Activated Partial Thromboplastin Time Clot Waveform Analysis In Hemophilia A
por: Maha Said, et al.
Publicado em: (2023-01-01)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
por: Rita Carlotta Santoro, et al.
Publicado em: (2023-06-01)

Medical conditions associated with Prolonged Activated Partial Thromboplastin time in Swat
por: Mukamil Shah, et al.
Publicado em: (2010-12-01)

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis
por: Yang F, et al.
Publicado em: (2024-01-01)

Effects of intravenous heparin on oxidation of fat
por: A. Michajlik, et al.
Publicado em: (1960-01-01)

Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study
por: Tomoyo Saito, et al.
Publicado em: (2023-11-01)

Prothrombin time and activated partial thromboplastin time in women with gestational diabetes mellitus
por: Samira Mahjabeen, et al.
Publicado em: (2023-01-01)

Unbelievable but true: Partial thromboplastin time, kaolin 120 s and yet no surgical bleed!
por: Shagun Bhatia Shah, et al.
Publicado em: (2017-01-01)

Activated partial thromboplastin time maybe associated with the prognosis of papillary thyroid carcinoma
por: Wang Yanhai, et al.
Publicado em: (2022-10-01)

Effect of Pre-Analytic Variables on Prothrombin Time and Activated Partial Thromboplastin Time
por: Garima M Anandani, et al.
Publicado em: (2018-07-01)

Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample.
por: Manu N Capoor, et al.
Publicado em: (2015-01-01)

Analysis of D-Dimer Level and Prothombin Time (PT) Activated Prothombin Thromboplastin (APTT) on Heparin Administration to COVID-19 Patients
por: Dela Yorike, et al.
Publicado em: (2022-04-01)

Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values.
por: Ying Zhao, et al.
Publicado em: (2011-01-01)

Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
por: Pearce Michael I, et al.
Publicado em: (2011-10-01)

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time
por: Maryam Sotoudeh Anvari, et al.
Publicado em: (2018-02-01)

Safety of Tonsillectomy and/or Adenoidectomy in Pediatric Patients with Prolonged Activated Partial Thromboplastin Time and Factor XII Deficiency
por: Du J, et al.
Publicado em: (2024-05-01)

Interferensi Hematokrit Tinggi Terhadap Pemeriksaan Prothrombin Time dan Activated Partial Thromboplastin Time
por: Hevrina Yufani, et al.
Publicado em: (2021-11-01)

The Effects of Plasma Prothrombin Time and Activated Partial Thromboplastin Time Based on Different Instruments and Methods
por: Yetti Hernaningsih, et al.
Publicado em: (2019-09-01)

Evaluation of vitamin D effects and relationships with partial thromboplastin time in patients with acute coronary syndrome
por: Haleh Bodagh, et al.
Publicado em: (2020-02-01)

A retrospective study of the prevalence of isolated prolongation of activated partial thromboplastin time in the preoperative setting
por: Yasuhiro Watanabe, et al.
Publicado em: (2024-05-01)

Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
por: Luz Tarín-Arzaga, et al.
Publicado em: (2021-01-01)

The effect of endotracheal administration of N-acetyl cysteine and heparin on the level of secretion and partial thromboplastin time in acute respiratory distress syndrome patients under mechanical ventilation: A randomized clinical trial study
por: Farshad Yadollahi, et al.
Publicado em: (2022-08-01)

INTERNATIONAL NORMALIZED RATIO AND ACTIVATED PARTIAL THROMBOPLASTIN TIME DO NOT PREDICT PLASMA TRANSFUSION IN LIVER TRANSPLANTATION
por: David Silveira MARINHO, et al.
Publicado em: (2025-01-01)

Normalization of Activated Partial Thromboplastin Time Correlates with Low Levels of Dabigatran in a Patient with Severe Sepsis
por: Rikke Ebenhard Højland, et al.
Publicado em: (2015-01-01)

CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis [Letter]
por: Zainarda, et al.
Publicado em: (2024-01-01)

Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study
por: Wan Hui Wong, et al.
Publicado em: (2023-07-01)

The Effect of 8-Weeks Exercise in Water on Factor VIII and Partial Thromboplastin Time (PTT) of Men with Hemophilia
por: Marziyeh Soltani, et al.
Publicado em: (2016-01-01)

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time
por: Sang-Min Kim, et al.
Publicado em: (2021-06-01)

Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
por: Daniel Aston DPhil, et al.
Publicado em: (2022-12-01)

Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A
por: Rutvi G Dave, et al.
Publicado em: (2021-01-01)